A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS

The New England Journal of Medicine
F GordinW El-Sadr

Abstract

Patients with human immunodeficiency virus (HIV) infection and latent tuberculosis are at substantial risk for the development of active tuberculosis. As a public health measure, prophylactic treatment with isoniazid has been suggested for HIV-infected persons who have anergy and are in groups with a high prevalence of tuberculosis. We conducted a multicenter, randomized, double-blind, placebo-controlled trial of six months of prophylactic isoniazid treatment in HIV-infected patients with anergy who have risk factors for tuberculosis infection. The primary end point was culture-confirmed tuberculosis. The study was conducted from November 1991 through June 1996. Over 90 percent of the patients had two or more risk factors for tuberculosis infection, and nearly 75 percent of patients were from greater New York City. After a mean follow-up of 33 months, tuberculosis was diagnosed in only 6 of 257 patients in the placebo group and 3 of 260 patients in the isoniazid group (risk ratio, 0.48; 95 percent confidence interval, 0.12 to 1.91; P=0.30). There were no significant differences between the two groups with regard to death, death or the progression of HIV disease, or adverse events. Even in HIV-infected patients with anergy and m...Continue Reading

References

Dec 1, 1992·The American Review of Respiratory Disease
Feb 11, 1992·The American Review of Respiratory Disease·D E Snider, G J Caras
Jun 6, 1991·The New England Journal of Medicine·P F BarnesD E Snider
Mar 28, 1986·JAMA : the Journal of the American Medical Association·D E SniderJ P Koplan
Jul 27, 1995·The New England Journal of Medicine·T R FriedenM A Hamburg
Aug 1, 1993·Annals of Internal Medicine·S MorenoD López-Gay
Jun 1, 1996·American Journal of Respiratory and Critical Care Medicine·D P ChinP C Hopewell

❮ Previous
Next ❯

Citations

Mar 24, 2005·International Urology and Nephrology·S K AgarwalS C Tiwari
May 15, 2012·Current HIV/AIDS Reports·Anna K Person, Timothy R Sterling
Nov 14, 1998·Disease-a-month : DM·H W HorowitzG P Wormser
May 29, 2003·Journal of Clinical Anesthesia·Krzysztof M Kuczkowski
Dec 31, 1997·The New England Journal of Medicine·J M AguadoS Moreno
Feb 4, 1999·The New England Journal of Medicine·D V Havlir, P F Barnes
May 11, 2000·The New England Journal of Medicine·J A Kovacs, H Masur
Jul 21, 2001·The New England Journal of Medicine·P M Small, P I Fujiwara
Aug 20, 2004·The New England Journal of Medicine·William C TaylorStephen G Pauker
Jul 29, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D L Cohn
Dec 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·José L CasadoFernando Dronda
Dec 23, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jerod N ScholtenPaula I Fujiwara
Aug 30, 2007·The Journal of Infectious Diseases·Gavin J ChurchyardRichard E Chaisson
Dec 3, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert G DeissRichard S Garfein
Sep 9, 2011·AIDS Research and Human Retroviruses·Mana KhongphatthanayothinPraphan Phanuphak
Sep 21, 2001·Journal of Urban Health : Bulletin of the New York Academy of Medicine·D C PerlmanD C Des Jarlais
Nov 26, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·A Korzets, U Gafter
Oct 31, 2001·AIDS·J L JohnsonUNKNOWN Uganda-Case Western Reserve University Research Collaboration
May 6, 1999·Current Opinion in Pulmonary Medicine·C S HirschJ J Ellner
Apr 27, 2000·Current Opinion in Pulmonary Medicine·J L Johnson, J J Ellner
May 24, 2001·Current Opinion in Pulmonary Medicine·R S Wallis, J L Johnson
Apr 9, 2005·Current Opinion in Pulmonary Medicine·Keertan DhedaGraham A W Rook
Sep 29, 2011·HIV Medicine·A L PozniakUNKNOWN BHIVA Guidelines Subcommittee
May 8, 2008·American Journal of Respiratory and Critical Care Medicine·Jason E Stout, Dick Menzies
Apr 10, 2010·American Journal of Respiratory and Critical Care Medicine·Zegabriel TedlaTaraz Samandari
May 18, 2006·Emerging Infectious Diseases·Maria Elvira BalcellsAlison D Grant
May 1, 2010·Bulletin of the World Health Organization·Anand A DateCharlie Gilks
Jul 15, 1998·American Journal of Public Health·C R Horsburgh
Mar 1, 2006·Expert Opinion on Drug Safety·Eric J Forget, Dick Menzies
Aug 21, 2013·Primary Care·Jarrett K Sell
Oct 21, 1998·Infectious Disease Clinics of North America·D E Griffith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.